Proceedings of the National Academy of Sciences · 2013 · 47 citations · 21 references
Life SciencesImmunologyPathologyAutoimmunityImmunopathologyInflammationAutoimmune Disease PathogenesisAutoimmune Disease PathologyAutoimmune DiseasesAutoimmune PathogenesisB Cell BiologyImmune-mediated DiseaseB Cell - Mediated AutoimmunityB Cell DysfunctionB Cell-mediated PathologyB-cell PathogenesisImmune System DisruptionRegulatory B Cell FunctionRegulatory B Cell ResponsesSystemic Autoimmune Disease Association
Impaired regulatory T-cell function results in a severe chronic autoimmune disease affecting multiple organs in Scurfy mice and humans with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Previous studies have shown that T helper cells but not cytotoxic T cells are critical for the disease pathology. Whether this T-cell subset is responsible directly for tissue inflammation or rather indirectly via the interaction with B cells or myeloid cells is largely unknown. To study this and to identify potential therapeutic targets for this lethal disease we investigated the contribution of B cells to this complex autoimmune phenotype. We show that B cells and the production of autoantibodies plays a major role for skin, liver, lung, and kidney inflammation and therapeutic depletion of B cells resulted in reduced tissue pathology and in prolonged survival. In contrast, the absence of B cells did not impact systemic T-cell activation and hyperreactivity, indicating that autoantibody production by B cells may be a major factor for the autoimmune pathology in mice deficient for regulatory T cells.
21
Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions
Yeonseok Chung, Shinya Tanaka, Fuliang Chu et al. · Nature Medicine · 2011 · 1.1K citations · Full text
Shimon Sakaguchi, K Fukuma, Kagemasa Kuribayashi et al. · The Journal of Experimental Medicine · 1985 · 713 citations · Full text
Life Sciences, Immunology, Pathology +17